BRIDGE Sweden

Purpose and goal

The goal of BRIDGE Sweden is to strengthen Sweden´s position as a global player within Life Science, specifically in research, development and production of biopharmaceuticals support the investment in precision medicine. By connecting, developing and improving the collaboration and handover between already existing national research infrastructures and the regional innovation support, BRIDGE Sweden will fill today´s technical and process-related gaps and contribute to streamlining the development of biological medicines in Sweden.

Expected effects and result

A seamless and complete innovation support from basic research to full -scale production of finished product contributes to: Minimized risk that researchers and small companies are forced to seek help outside Sweden Minimized risk for international ownership capital Minimized risk that companies establish their production capacity abroad Increased likelihood that IP and expertise remains in Sweden. Increased potential to attract foreign companies to relocate and establish RnD activities and production in Sweden

Planned approach and implementation

The BRIDGE project will create a platform and pipeline for more uniform, efficient and less costly development of biological drugs from candidate to active substance by harmonizing methods and routines for evaluation, development and follow-up of early commercial drug projects at national level. The platform will ensure that business development takes place in parallel with technical development and the method will be verified with case projects from universities and small companies. The project will also establish a network of financiers, technology suppliers and experts.